Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127015882 | 12701588 | 2 | F | 201603 | 20160818 | 20160831 | 20160901 | EXP | CA-BAUSCH-BL-2016-018407 | BAUSCH AND LOMB | 47.73 | YR | F | Y | 95.34000 | KG | 20160901 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127015882 | 12701588 | 1 | PS | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | Oral | Y | 21515 | 300 | MG | TABLET | QD | ||||||
127015882 | 12701588 | 2 | SS | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | Oral | Y | 21515 | TABLET | |||||||||
127015882 | 12701588 | 3 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 0 | 225 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127015882 | 12701588 | 3 | Depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127015882 | 12701588 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127015882 | 12701588 | Lichenoid keratosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127015882 | 12701588 | 1 | 20090814 | 201607 | 0 | |
127015882 | 12701588 | 2 | 20160715 | 20160722 | 0 | |
127015882 | 12701588 | 3 | 20090814 | 0 |